AMGN

Amgen Inc. · BIVA:AMGN

8,500.00 MXN119.00 +1.42%

Amgen Inc. (BIVA:AMGN) last traded at 8,500.00 MXN, up 1.42% on the day. Over the past year the stock is up 58.03%. Its 52-week range is 5,476.66 to 8,500.00. It is in the Health Technology sector (Biotechnology).

Key statistics

Open8,434.45

Day range8,434.45 – 8,500.00

52-week range5,476.66 – 8,500.00

Volume8

Average volume (10 days)16

Market cap (USD)251.94 B

P/E30.17

EPS (TTM) (USD)16.10

Dividend yield2.13%

Beta (1 year)0.1774

Revenue (TTM) (USD)38.20 B

Employees31.50 K

Performance

+6.29%1 week

+19.76%1 month

+34.73%3 months

+41.74%6 months

+43.27%Year to date

+58.03%1 year

Technical rating

Buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

7,620.26 MXN

The average 1-year price target, −10.35% from the last price. See the forecast

Latest headlines

Amgen (AMGN) reports Q3: everything you need to know ahead of earningsStock Story · 02 Nov 2026
Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week — Barrons.comDow Jones Newswires · 01 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Big Homes, Big Loans — Barrons.comDow Jones Newswires · 30 Oct 2026
Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
Steve Jobs' Son Says GLP-1 Weight Loss Drugs Could Be Among Most Important Medicines Ever, With Potential Impact on CancerBenzinga · 29 Oct 2026
Amgen Q3 Earnings: Will Strong Drug Sales Offset Headwinds?Zacks · 28 Oct 2026
FDA warns Amgen over cancer drug promotional videoReuters · 28 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.